StepWise USMLE
endocrine pathology · core

Thyroid · Parathyroid · Adrenal · Pituitary · DM

High‑yield notes for clinical reasoning & board review

🧠 Thyroid goiter · hyper/hypo · neoplasia

  • Goiter – enlarged thyroid with multiple colloid nodules
    • most often euthyroid (normal T4/T3/TSH)
    • Plummer syndrome = late hyperthyroidism (toxic multinodular)
    • endemic goiter: iodine deficiency (rare in US)
    • micro: nodules of varying size, colloid follicles, calcification, hemorrhage, fibrosis
  • Hyperthyroidism – ↑ metabolic rate due to ↑ T4/T3
    • symptoms: tachycardia, heat intolerance, tremor, diarrhea, weight loss with appetite
    • primary hyperthyroidism: ↓ TSH, ↑ free T4
    • secondary/tertiary: ↑ TSH, ↑ free T4
  • Graves disease – autoimmune (TSI antibodies to TSH receptor)
    • female >> male, peak 20–40
    • features: hyperthyroidism, diffuse goiter, ophthalmopathy (exophthalmos), pretibial myxedema
    • micro: hyperplastic follicles, scalloped colloid
  • Hypothyroidism – ↓ metabolic rate due to ↓ T4/T3
    • symptoms: fatigue, cold intolerance, myxedema, macroglossia, constipation, anovulation
    • primary: ↑ TSH, ↓ free T4
    • secondary/tertiary: ↓ TSH, ↓ free T4
    • most common cause in US: iatrogenic (post-thyroidectomy / radioactive iodine)
  • Thyroiditis
    • Hashimoto – autoimmune, most common non-iatrogenic hypothyroidism; female 40–65; painless goiter; risk of B-cell lymphoma; micro: lymphocytic infiltrate, germinal centers, Hürthle cells
    • Subacute (de Quervain) – post-viral, tender goiter, transient hyperthyroidism; granulomatous
    • Riedel – rare, dense fibrosis, hard thyroid adherent to trachea/esophagus; associated with retroperitoneal fibrosis
  • Thyroid neoplasia
    • Papillary carcinoma (80%): female 20–50, radiation exposure; RET rearrangements; psammoma bodies, Orphan Annie nuclei, grooves; excellent prognosis
    • Follicular carcinoma (15%): female 40–60; hematogenous spread (bone/lung); capsular invasion distinguishes from adenoma
    • Medullary carcinoma (5%): C-cell origin, secretes calcitonin; amyloid stroma; 25% familial (MEN2); RET mutations
    • Anaplastic – aggressive, >60, rapidly fatal
    • TSH is the most sensitive test – normal TSH = euthyroid

🦴 Parathyroid hyper · hypo · brown tumors

  • Primary hyperparathyroidism – excess PTH
    • causes: adenoma (80%), hyperplasia (15%), carcinoma (rare)
    • ↑ serum calcium, ↑ PTH
    • manifestations: kidney stones, osteoporosis, osteitis fibrosa cystica (brown tumors), neuropsychiatric
  • Secondary hyperparathyroidism – due to hypocalcemia (chronic renal failure, vitamin D deficiency, malabsorption) → compensatory ↑ PTH
  • Hypoparathyroidism – low PTH
    • causes: surgical removal, DiGeorge, autoimmune (AIRE mutations)
    • symptoms: muscle spasms, tingling, prolonged QT, psychiatric
    • treatment: vitamin D + calcium
    • Osteitis fibrosa cystica = bone resorption, cystic lesions, brown tumors – classic in primary hyperparathyroidism

🧬 Pituitary & Pineal adenomas · DI · SIADH

  • Pituitary adenomas – micro (<1cm) vs macro (>1cm); macroadenomas cause visual field defects
    • Prolactinoma – most common; galactorrhea, amenorrhea, impotence
    • Nonfunctional – hypopituitarism
    • GH-producing – gigantism (children) / acromegaly (adults); ↑ IGF-1
  • Sheehan syndrome – ischemic necrosis postpartum hemorrhage → panhypopituitarism
  • Diabetes insipidus – ADH deficiency (central) or renal resistance (nephrogenic)
    • central: head trauma, tumors → hypotonic polyuria, hypernatremia
    • nephrogenic: lack of renal response
  • SIADH – excess ADH → water retention, hyponatremia, cerebral edema
    • common causes: small cell lung cancer, drugs (carbamazepine, SSRIs, cyclophosphamide)
  • Craniopharyngioma – Rathke pouch remnant, most common hypopituitarism in children
  • Pineal – calcification (landmark); germ cell tumors (rare)
    • 75% pituitary destruction → panhypopituitarism (thyroid, adrenal, gonadal axes)

⚡ Adrenal Cushing · aldosterone · insufficiency · pheo

  • Cushing syndrome – glucocorticoid excess
    • most common: exogenous steroids
    • endogenous: Cushing disease (pituitary ACTH), ectopic ACTH (small cell lung), adrenal neoplasm
    • clinical: truncal obesity, buffalo hump, moon facies, striae, hypertension, hirsutism
  • Hyperaldosteronism – hypertension, hypokalemia
    • primary (↓ renin): Conn syndrome (adenoma), bilateral hyperplasia
    • secondary (↑ renin): renal artery stenosis
  • Adrenogenital syndromes – androgen excess, virilization
    • congenital adrenal hyperplasia (21-hydroxylase deficiency most common) or adrenocortical tumor
  • Adrenal insufficiency
    • Waterhouse-Friderichsen – acute, bilateral hemorrhage, sepsis (N. meningitidis), DIC, shock
    • Addison disease – chronic autoimmune destruction; weakness, hyperpigmentation, hypotension, hypoglycemia
    • secondary (hypothalamic/pituitary) – no hyperpigmentation (low ACTH)
  • Pheochromocytoma – catecholamine-producing tumor (adrenal medulla)
    • sustained or episodic hypertension, headache, palpitations, diaphoresis
    • rule of 10s: 10% children, bilateral, malignant, familial, extra-adrenal
    • elevated urinary VMA & catecholamines; Zellballen pattern
    • Dexamethasone suppression test: in Cushing disease (pituitary) → ↓ cortisol; in ectopic/neoplasia → no suppression

🧩 MEN Syndromes MEN1 · MEN2A · MEN2B

  • MEN1 (Werner) – pituitary, parathyroid, pancreatic tumors; Zollinger-Ellison; MEN1 gene (menin)
  • MEN2A (Sipple) – medullary thyroid carcinoma, pheochromocytoma, parathyroid hyperplasia; RET mutation
  • MEN2B – medullary thyroid carcinoma, pheochromocytoma, mucocutaneous neuromas; RET mutation
    • Autosomal dominant, incomplete penetrance; tumors occur at young age

🩸 Diabetes Mellitus type 1 · type 2 · complications

  • Diagnosis – fasting glucose ≥126 mg/dL (two occasions), or HbA1c ≥6.5%
  • Type 1 (10%) – young, autoimmune β-cell destruction (coxsackie B trigger, HLA DR3/DR4)
    • absolute insulin deficiency; 3Ps, DKA; insulitis (lymphocytic); treatment: insulin
  • Type 2 (90%) – obesity, insulin resistance, relative deficiency
    • often asymptomatic; hyperosmolar coma possible; amyloid deposition in islets
    • treatment: diet, oral agents, insulin
  • Vascular complications – atherosclerosis → MI, stroke, PVD
    • nephropathy: glomerular lesions, arteriolosclerosis
    • retinopathy: nonproliferative (microaneurysms, exudates) → proliferative (neovascularization)
    • neuropathy: peripheral, autonomic (bladder, impotence)
    • Myocardial infarction is the most common cause of death in DM
    Type 1
    • HLA DR3/DR4
    • Islet lymphocytic infiltrate
    • Ketoacidosis prone
    • Insulin dependent
    Type 2
    • Obesity association
    • Amyloid in islets
    • Non-ketotic hyperosmolar coma
    • May be managed without insulin